BILLS-109hr5975ih.pdf

04:47 Jul 30, 2006 5975 VerDate Aug 31 2005 JULY 28, 2006 5 year 2008 1905 21 each subsequent fiscal year 20:31 Aug 01, 2006 ANNUAL REPORT.—Each year 31 2005 4 year 2007 SAFETY.—Within 12 months later than a year 2006

SESSION H. R. 5975 the ‘‘Prescription Drug

PO 00000 Frm 00004 PO 00000 Frm 00006 PO 00000 Frm PO 00000 Frm 00001

Indiana Ohio the United States of America

IH

APPROPRIATIONS.—To

Healthcare Research and Quality the National Institutes of Health Agency the Agency for Healthcare Research and Quality Congress Health and Human Services ACCOUNTABILITY.—In House of Representa- SEC Health care & Medicaid Services Food and Drugs THE HOUSE OF REPRESENTATIVES the Indian Health Service Senate Defense the National Institutes of 7 Health the National Institutes of 9 Health Veterans Affairs Healthcare tional Institutes of Health the Office of Personnel Energy and Commerce

WAXMAN ALLEN GUT- KNECHT EMERSON EHLERS BURTON BROWN

healthcare institutes health clinical institutes national institutes director national prescription drugs director research outcomes effectiveness drugs evidence treatments quality